Tag Archives: pay-for-delay

Budget Cutters Propose Big Hits on Pharma

By Guest Blogger | Published: April 17, 2013
By Jill Wechsler, Washington Correspondent. The Obama administration’s budget plan for fiscal year 2014 apparently assumes that the pharmaceutical industry can support Medicare and other health programs through changes in drug coverage and payments. It also relies on industry fees to keep the Food and Drug Administration up and running. Meanwhile, FDA and other public health [...]
Posted in Guest Blog, Op-Ed, healthcare | Also tagged , , , , , , | Leave a comment

FTC v. Actavis: The Wrong End of the Telescope

By Guest Blogger | Published: March 25, 2013
by Traci Medford-Rosow and Peter C. Richardson On December 8, 2012, the Supreme Court agreed to hear the Federal Trade Commission (FTC) v. Actavis, Inc. case. The court’s grant of certiorari marked the latest chapter in a decade-long effort by the FTC to have the court rule on the festering issue of whether pay-for-delay provisions in [...]
Posted in IP, Legal, Market Access, Op-Ed, Regulatory, Strategy | Also tagged | 1 Comment

Obama Reveals Healthcare Reform Plan

By Jill Wechsler | Published: February 22, 2010
Image via Wikipedia The health reform proposal unveiled by the White House on Feb. 22, 2010 retains a number of provisions that directly affect drug coverage and industry revenues. The plan highlights that it will close the Medicare drug benefit “doughnut hole” by 2020 to make drugs more affordable to the elderly. Seniors will get some [...]
Posted in News, Regulatory | Also tagged , , , , | 4 Comments